BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 15061372)

  • 1. Current concepts in standardization of cardiac marker immunoassays.
    Panteghini M
    Clin Chem Lab Med; 2004 Jan; 42(1):3-8. PubMed ID: 15061372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An immunoprecipitation coupled with fluorescent Western blot analysis for the characterization of a model secondary serum cardiac troponin I reference material.
    He HJ; Lowenthal MS; Cole KD; Bunk D; Wang L
    Clin Chim Acta; 2011 Jan; 412(1-2):107-11. PubMed ID: 20869361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of biochemical markers in acute coronary syndromes. IFCC Scientific Division, Committee on Standardization of Markers of Cardiac Damage. International Federation of Clinical Chemistry.
    Panteghini M; Apple FS; Christenson RH; Dati F; Mair J; Wu AH
    Clin Chem Lab Med; 1999 Jun; 37(6):687-93. PubMed ID: 10475079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Method comparison of cardiac marker assays on PATHFAST, StratusCS, AxSYM, Immulite 2000, triage, elecsys and cardiac reader.
    Peetz D; Schweigert R; Jachmann N; Post F; Schinzel H; Lackner KJ
    Clin Lab; 2006; 52(11-12):605-14. PubMed ID: 17175892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the chemiluminescence immunoassays for the measurement of troponin I, myoglobin and CK-MB using the IMMULITE system in comparison to other measuring systems.
    Lestin M; Hergert M; Lestin HG; Brinker C; Storm H; Kuhrt E; Kuhrt B; Lambrecht HG; Kühnel W
    Clin Lab; 2002; 48(3-4):211-21. PubMed ID: 11934224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Standardization of cardiac markers.
    Apple FS
    Scand J Clin Lab Invest Suppl; 2005; 240():107-11. PubMed ID: 16112967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Standardization of immunoassays.
    Masseyeff RF
    Ann Ist Super Sanita; 1991; 27(3):427-36. PubMed ID: 1725576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent approaches to the standardization of cardiac markers.
    Panteghini M
    Scand J Clin Lab Invest; 2001 Apr; 61(2):95-101. PubMed ID: 11347986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blu-ray Technology-Based Quantitative Assays for Cardiac Markers: From Disc Activation to Multiplex Detection.
    Weng S; Li X; Niu M; Ge B; Yu HZ
    Anal Chem; 2016 Jul; 88(13):6889-96. PubMed ID: 27268387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proposals from the IFCC Committee on Standardization of Markers of Cardiac Damage (C-SMCD): strategies and concepts on standardization of cardiac marker assays.
    Dati F; Panteghini M; Apple FS; Christenson RH; Mair J; Wu AH
    Scand J Clin Lab Invest Suppl; 1999; 230():113-23. PubMed ID: 10389209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Standardization of immunoassays for measurement of myoglobin in serum. Phase I: evaluation of candidate secondary reference materials.
    Panteghini M; Linsinger T; Wu AH; Dati F; Apple FS; Christenson RH; Mair J; Schimmel H
    Clin Chim Acta; 2004 Mar; 341(1-2):65-72. PubMed ID: 14967160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality management and international standardization programs for protein immunoassays.
    Dati F
    Anticancer Res; 1997; 17(4B):3161-4. PubMed ID: 9329626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic utility of new immunoassays for the cardiac markers cTnI, myoglobin and CK-MB mass.
    Weber M; Rau M; Madlener K; Elsaesser A; Bankovic D; Mitrovic V; Hamm C
    Clin Biochem; 2005 Nov; 38(11):1027-30. PubMed ID: 16125162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of cardiac troponins.
    Collinson PO; Boa FG; Gaze DC
    Ann Clin Biochem; 2001 Sep; 38(Pt 5):423-49. PubMed ID: 11587122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The immunoassay of cytokines and growth factors in biological fluids.
    Kopp W; Reynolds C; Ruscetti F
    Dev Biol Stand; 1999; 97():29-37. PubMed ID: 10463528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic strategies in myocardial infarction using myoglobin measurement.
    Plebani M; Zaninotto M
    Eur Heart J; 1998 Nov; 19 Suppl N():N12-5. PubMed ID: 9857933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The measurement of cardiac markers: where should we focus?
    Panteghini M
    Am J Clin Pathol; 2002 Sep; 118(3):354-61. PubMed ID: 12219777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imprecision of cardiac marker analyses among laboratories on the basis of external quality assurance results: Finnish experience.
    Penttilä IM; Laatikainen A; Penttilä K; Punnonen K; Rantanen T; Savolainen K; Tiikkainen U
    Scand J Clin Lab Invest; 2007; 67(5):507-18. PubMed ID: 17763187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Standardization in laboratory medicine: new challenges.
    Panteghini M; Forest JC
    Clin Chim Acta; 2005 May; 355(1-2):1-12. PubMed ID: 15820472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Standardization of immunoassays for hapten analytes.
    Gosling JP
    Scand J Clin Lab Invest Suppl; 1991; 205():95-104. PubMed ID: 1947754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.